share_log

Co-Diagnostics Q1 2024 GAAP EPS $(0.31) Misses $(0.21) Estimate, Sales $467.854K Miss $3.050M Estimate

Benzinga ·  May 9 16:18

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.21) by 47.62 percent. This is a 55 percent decrease over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $467.854 thousand which missed the analyst consensus estimate of $3.050 million by 84.66 percent. This is a 22.28 percent decrease over sales of $601.957 thousand the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment